RASSF1 and neoplasm: Pathway analysis showed activation of the transforming growth factor-β pathway in YSTs, which is associated with the overexpression of GATA6 and FOXA2 and the hypermethylation of tumor-suppressor genes (e.g., RASSF1, RUNX3, HIC1, or APC).